{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:25:32Z","timestamp":1791919532004,"version":"4.3.4"},"reference-count":44,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"unspecified","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,2,12]]},"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>This study aims to characterise oxycodone\u2019s distribution and opioid-related overdoses in the USA by state from 2000 to 2021.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>This is an observational study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>More than 80\u2009000 Americans died of an opioid overdose in 2021 as the USA continues to struggle with an opioid crisis. Prescription opioids play a substantial role, introducing patients to opioids and providing a supply of drugs that can be redirected to those seeking to misuse them.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The Drug Enforcement Administration annual summary reports from the Automation of Reports and Consolidated Orders System provided weights of oxycodone distributed per state by business type (pharmacies, hospitals and practitioners). Weights were converted to morphine milligram equivalents (MME) per capita and normalised for population. The Centers for Disease Control and Prevention Wide-ranging ONline Data for Epidemiologic Research provided mortality data for heroin, other opioids, methadone, other synthetic narcotics and other\/unspecified narcotics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There was a sharp 280.13% increase in total MME\/person of oxycodone from 2000 to 2010, followed by a slower 54.34% decrease from 2010 to 2021. Florida (2007\u20132011), Delaware (2003\u20132020) and Tennessee (2012\u20132021) displayed consistent and substantial elevations in combined MME\/person compared with other states. In the peak year (2010), there was a 15-fold difference between the highest and lowest states. MME\/person from only pharmacies, which constituted &gt;94% of the total, showed similar results. Hospitals in Alaska (2000\u20132001, 2008, 2010\u20132021), Colorado (2008\u20132021) and DC (2000\u20132011) distributed substantially more MME\/person over many years compared with other states. Florida stood out in practitioner-distributed oxycodone, with an elevation of almost 15-fold the average state from 2006 to 2010. Opioid-related deaths increased +806% from 2000 to 2021, largely driven by heroin, other opioids and other synthetic narcotics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Oxycodone distribution across the USA showed marked differences between states and business types over time. Investigation of opioid policies in states of interest may provide insight for future actions to mitigate opioid misuse.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2023-073765","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T10:35:14Z","timestamp":1709807714000},"page":"e073765","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["State-level variation in distribution of oxycodone and opioid-related deaths from 2000 to 2021: an ecological study of ARCOS and CDC WONDER data in the USA"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5822-9826","authenticated-orcid":false,"given":"Jay P","family":"Solgama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4716-055X","authenticated-orcid":false,"given":"Edward","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7903-3993","authenticated-orcid":false,"given":"Mellar","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7881-8588","authenticated-orcid":false,"given":"Jove","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth L","family":"McCall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J","family":"Piper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,3,7]]},"reference":[{"key":"2024043021502856000_14.3.e073765.1","unstructured":"Ahmad FB , Cisewski JA , Rossen LM , et al . Provisional drug overdose death counts. National Center for Health Statistics, 2022."},{"key":"2024043021502856000_14.3.e073765.2","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jamapsychiatry.2014.366","article-title":"The changing face of heroin use in the United States: a retrospective analysis of the past 50 years","volume":"71","author":"Cicero","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"2024043021502856000_14.3.e073765.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.01.010"},{"key":"2024043021502856000_14.3.e073765.4","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41380-020-0661-4","article-title":"The changing opioid crisis: development, challenges and opportunities","volume":"26","author":"Volkow","year":"2021","journal-title":"Mol Psychiatry"},{"key":"2024043021502856000_14.3.e073765.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2017.06.010"},{"key":"2024043021502856000_14.3.e073765.6","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000717"},{"key":"2024043021502856000_14.3.e073765.7","first-page":"97","article-title":"Fourth wave of opioid (illicit drug) overdose deaths and diminishing access to prescription opioids and Interventional techniques: cause and effect","volume":"25","author":"Manchikanti","year":"2022","journal-title":"Pain Physician"},{"key":"2024043021502856000_14.3.e073765.8","doi-asserted-by":"crossref","first-page":"101198","DOI":"10.1016\/j.eclinm.2021.101198","article-title":"Global consumption of prescription opioid analgesics between 2009-2019: a country-level observational study","volume":"42","author":"Jayawardana","year":"2021","journal-title":"eClinicalMedicine"},{"key":"2024043021502856000_14.3.e073765.9","unstructured":"Substance Abuse and Mental Health Services Administration . Key Substance Use and Mental Health Indicators in the United States: Results from the 2020 National Survey on Drug Use and Health. 2020: 156. Available: https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt35325\/NSDUHFFRPDFWHTMLFiles2020\/2020NSDUHFFR1PDFW102121.pdf"},{"key":"2024043021502856000_14.3.e073765.10","doi-asserted-by":"crossref","DOI":"10.1007\/s11916-019-0751-7","article-title":"Oxycodone\u2019s unparalleled addictive potential: is it time for a moratorium?","volume":"23","author":"Remillard","year":"2019","journal-title":"Curr Pain Headache Rep"},{"key":"2024043021502856000_14.3.e073765.11","unstructured":"U.S. Food and Drug Administration . FDA briefing document: joint meeting of anesthetic and analgesic drug products advisory committee and drug safety and risk management advisory committee. 2020. Available: https:\/\/www.fda.gov\/media\/143368\/download"},{"key":"2024043021502856000_14.3.e073765.12","first-page":"e41","article-title":"Trends in prescriptions for oxycodone and other commonly used opioids in the United States, 2000\u20132010","volume":"6","author":"Kenan","year":"2012","journal-title":"Open Med"},{"key":"2024043021502856000_14.3.e073765.13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258526","article-title":"Urban scaling of opioid analgesic sales in the united states","volume":"16","author":"Mullachery","year":"2021","journal-title":"PLoS One"},{"key":"2024043021502856000_14.3.e073765.14","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.8108","article-title":"Dynamic changes in prescription opioids from 2006 to 2017 in Texas","volume":"7","author":"Ighodaro","year":"2019","journal-title":"PeerJ"},{"key":"2024043021502856000_14.3.e073765.15","doi-asserted-by":"crossref","unstructured":"Eufemio CM , Hagedorn JD , McCall KL , et al . An analysis of oxycodone and hydrocodone distribution trends in delaware, maryland, & virginia between 2006-2014. Pain Medicine [Preprint] 2022. doi:10.1101\/2022.07.16.22277708","DOI":"10.1101\/2022.07.16.22277708"},{"key":"2024043021502856000_14.3.e073765.16","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.6272","article-title":"Opioid distribution trends (2006\u20132017) in the US territories","volume":"7","author":"Cabrera","year":"2019","journal-title":"PeerJ"},{"key":"2024043021502856000_14.3.e073765.17","unstructured":"Aitken M , Kleinrock M , Campbell A , et al . Prescription opioid trends in the United States. IQVIA Institute, 2020: 24. Available: https:\/\/www.iqvia.com\/-\/media\/iqvia\/pdfs\/institute-reports\/prescription-opioid-trends-in-the-united-states\/iqi-prescription-opioid-trends-in-the-us-1220-forweb.pdf?_=1664160974509"},{"key":"2024043021502856000_14.3.e073765.18","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1097\/j.pain.0000000000002473","article-title":"Declines and regional variation in opioid distribution by U.S. hospitals","volume":"163","author":"Eidbo","year":"2022","journal-title":"Pain"},{"key":"2024043021502856000_14.3.e073765.19","unstructured":"Centers for Disease Control and Prevention, National Center for Health Statistics . Data from: multiple cause of death 1999 - 2020. CDC WONDER database. 2023. Available: http:\/\/wonder.cdc.gov\/mcd-icd10.html"},{"key":"2024043021502856000_14.3.e073765.20","unstructured":"U.S . Diversion control division. Data from: automation of reports and consolidated orders system. ARCOS retail drug summary reports. 2022. Available: https:\/\/www.deadiversion.usdoj.gov\/arcos\/retail_drug_summary\/index.html"},{"key":"2024043021502856000_14.3.e073765.21","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2020.615646","article-title":"Assessment of controlled substance distribution to U.S. veterinary teaching institutions from 2006 to 2019","volume":"7","author":"Piper","year":"2020","journal-title":"Front Vet Sci"},{"key":"2024043021502856000_14.3.e073765.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2018.01.034"},{"key":"2024043021502856000_14.3.e073765.23","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2015.302953"},{"key":"2024043021502856000_14.3.e073765.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.12.025"},{"key":"2024043021502856000_14.3.e073765.25","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1097\/PTS.0000000000000710","article-title":"The effect of opioid stewardship interventions on key outcomes: a systematic review","volume":"16","author":"Shoemaker-Hunt","year":"2020","journal-title":"J Patient Saf"},{"key":"2024043021502856000_14.3.e073765.26","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.jiph.2020.06.035","article-title":"Prescription drug monitoring programs in the US: a systematic literature review on its strength and weakness","volume":"13","author":"Alogaili","year":"2020","journal-title":"J Infect Public Health"},{"key":"2024043021502856000_14.3.e073765.27","unstructured":"Key substance use and mental health indicators in the United States: results from the 2022 national survey on drug use and health. 2022."},{"key":"2024043021502856000_14.3.e073765.28","unstructured":"US Food and Health Administration . Timeline of selected FDA activities and significant events addressing opioid misuse and abuse. n.d. Available: https:\/\/www.fda.gov\/drugs\/information-drug-class\/timeline-selected-fda-activities-and-significant-events-addressing-opioid-misuse-and-abuse"},{"key":"2024043021502856000_14.3.e073765.29","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.235"},{"key":"2024043021502856000_14.3.e073765.30","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/jamainternmed.2015.0914","article-title":"Rates of opioid dispensing and overdose after introduction of abuse-deterrent extended-release Oxycodone and withdrawal of Propoxyphene","volume":"175","author":"Larochelle","year":"2015","journal-title":"JAMA Intern Med"},{"key":"2024043021502856000_14.3.e073765.31","unstructured":"2009 Florida statues title XLVI chapter 893 section 055. n.d. Available: http:\/\/www.leg.state.fl.us\/statutes\/index.cfm?mode=View%20Statutes&SubMenu=1&App_mode=Display_Statute&Search_String=Prescription+drug+monitoring+program&URL=CH0893\/Sec055.HTM"},{"key":"2024043021502856000_14.3.e073765.32","unstructured":"Macy B . Dopesick: dealers, doctors, and the drug company that addicted America. New York: Little Brown & Company, 2018. Available: https:\/\/ebook.yourcloudlibrary.com\/library\/BCPL-document_id-q8twt89"},{"key":"2024043021502856000_14.3.e073765.33","unstructured":"International Narcotics Control Board . Narcotic drugs \u2014 estimated world requirements for 2022 \u2014 Statistics for 2020. 2022: 502. Available: https:\/\/www.incb.org\/documents\/Narcotic-Drugs\/Technical-Publications\/2021\/Narcotic_Drugs_Technical_Publication_2021.pdf"},{"key":"2024043021502856000_14.3.e073765.34","unstructured":"Duff JH , Tharakan SM , Davis-Castro CY , et al . Consumption of prescription opioids for pain: a comparison of opioid use in the United States and other countries. Congressional Research Service, 2021: 48. Available: https:\/\/crsreports.congress.gov\/product\/pdf\/R\/R46805"},{"key":"2024043021502856000_14.3.e073765.35","unstructured":"OECD . Addressing problematic opioid use in OECD countries. n.d. Available: https:\/\/www.oecd.org\/health\/addressing-problematic-opioid-use-in-oecd-countries-a18286f0-en.htm"},{"key":"2024043021502856000_14.3.e073765.36","doi-asserted-by":"publisher","DOI":"10.7326\/M18-1243"},{"key":"2024043021502856000_14.3.e073765.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jse.2020.07.016"},{"key":"2024043021502856000_14.3.e073765.38","unstructured":"Washington Post . How to download and use the DEA pain pills database. n.d. Available: https:\/\/www.washingtonpost.com\/national\/2019\/07\/18\/how-download-use-dea-pain-pills-database\/"},{"key":"2024043021502856000_14.3.e073765.39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201193","article-title":"The number of Undocumented immigrants in the United States: estimates based on demographic modeling with data from 1990 to 2016","volume":"13","author":"Fazel-Zarandi","year":"2018","journal-title":"PLoS One"},{"key":"2024043021502856000_14.3.e073765.40","unstructured":"ClinCalc.com . The top 300 of 2020 provided by the Clincalc Drugstats database. n.d. Available: https:\/\/clincalc.com\/DrugStats\/Top300Drugs.aspx"},{"key":"2024043021502856000_14.3.e073765.41","doi-asserted-by":"crossref","first-page":"111579","DOI":"10.1016\/j.forsciint.2023.111579","article-title":"Examination of methadone involved overdoses during the COVID-19 pandemic","volume":"344","author":"Kaufman","year":"2023","journal-title":"Forensic Sci Int"},{"key":"2024043021502856000_14.3.e073765.42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC clinical practice guideline for prescribing opioids for pain - United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep"},{"key":"2024043021502856000_14.3.e073765.43","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2007.131714"},{"key":"2024043021502856000_14.3.e073765.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.04.033"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-073765","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T04:54:14Z","timestamp":1714539254000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-073765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":44,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3,7]]},"published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1136\/bmjopen-2023-073765"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-073765","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3]]}}}